Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
4.690
-0.040 (-0.85%)
Jan 9, 2026, 1:33 PM EST - Market open
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
$566,551
Profits / Employee
$68,675
Market Cap
1.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALVO News
- 1 day ago - Correction: Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 2 days ago - Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 8 days ago - Alvotech Secures Term Loan Facility of USD 100 Million - GlobeNewsWire
- 10 days ago - Changes in company's own shares - GlobeNewsWire
- 17 days ago - Alvotech's Financial Calendar for 2026 - GlobeNewsWire
- 18 days ago - Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma - GlobeNewsWire
- 22 days ago - Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman - PRNewsWire
- 23 days ago - Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering - GlobeNewsWire